From Dr. Joseph Mercola Since COVID-19 first entered the scene, exchange of ideas has basically been outlawed. By sharing my views and those from various experts throughout the pandemic on COVID treatments and the experimental COVID jabs, I became a main target of the White House, the political establishment and the global cabal. Propaganda and… Read More »
While the drug and chemical industries have attacked and tried to discredit me for years, blatant censorship didn’t begin until 2020, after the outbreak of the COVID pandemic. For legal and historical purposes, I am sharing a timeline of events with you that document a chain of coordinated events and attacks against me and this… Read More »
Three decades of successfully delivering digital private banking and wealth management solutions to the off-shore market Nassau, Bahamas, 26 January, 2023 – International Private Banking Systems (www.ipbs.com), has reached an exciting milestone as the company celebrates 30 years delivering flexible, robust private banking and wealth management solutions. The modular platform enables financial institutions to automate… Read More »
The U.S. Food and Drug Administration granted accelerated approval for the Alzheimer’s disease drug lecanemab (Leqembi). The drug, a monoclonal antibody, binds to amyloid beta in the brain. An 18-month study published in the New England Journal of Medicine1 found Leqembi reduced markers of amyloid in early Alzheimer’s disease and led to “moderately less decline”… Read More »